Zobrazeno 1 - 10
of 242
pro vyhledávání: '"Salasyuk AS"'
Autor:
Sergey V. Nedogoda, Marina V. Zhuravleva, Sergey N. Tereshchenko, Alla S. Salasyuk, Igor V. Zhirov, Irina N. Barykina, Viktoria O. Lutova, Ekaterina A. Popova
Publikováno v:
Терапевтический архив, Vol 96, Iss 8, Pp 771-779 (2024)
Aim. To evaluate the clinical and economic effectiveness of dapagliflozin in patients with chronic heart failure (CHF) with reduced left ventricular ejection fraction (HFrEF) in the Russian Federation in various subgroups of standard therapy for CHF.
Externí odkaz:
https://doaj.org/article/3fd97e36a00640bfba4c78ac473e450d
Autor:
M. M. Batyushin, M. A. Trubnikova, G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, D. S. Polyakov, S. Sh. Akhmedkhanov, I. G. Bakulin, I. A. Bodrievskaya, I. A. Viktorova, N. G. Vinogradova, A. S. Galyavich, N. P. Garganeeva, N. Yu. Grigorieva, S. B. Erofeeva, M. A. Kercheva, S. G. Kechedzhieva, N. A. Koryagina, S. V. Malchikova, V. A. Nevzorova, S. V. Nedogoda, M. M. Petrova, V. A. Pogrebetskaya, A. P. Rebrov, O. A. Rubanenko, E. A. Safianik, V. V. Skibitsky, E. A. Smirnova, E. A. Starovoitova, R. F. Khamitov, A. I. Chesnikova, T. M. Shabatina, I. I. Shaposhnik, A. R. Vaisberg, A. V. Aparkina, I. N. Barykina, T. I. Batluk, R. A. Bashkinov, A. T. Beybalayeva, Y. A. Belenikina, O. A. Bilevich, Zh. V. Bondareva, A. Yu. Vaskin, T. V. Vlasova, E. V. Galko, T. U. Garifullin, E. D. Gordeychuk, E. V. Grigorieva, I. V. Gubareva, L. K. Danilova, A. I. Dolgushina, E. M. Durygina, D. S. Evdokimov, N. V. Zhdankina, E. I. Zheleznyak, D. S. Zueva, D. S. Ivanova, E. Yu. Ivanchenko, M. V. Kazakovtseva, A. A. Kaznina, N. A. Karoli, D. S. Kaskaeva, Z. F. Kim, M. V. Kozlova, Y. I. Kudrinskaya, A. S. Kuznetsova, E. Yu. Levchenko, I. A. Lukonin, V. O. Lutova, N. A. Magdeeva, E. V. Makarova, N. E. Makarova, M. M. Mamontova, E. S. Melnikov, A. F. Molostvova, T. D. Naborshchikova, I. N. Nikitina, D. P. Novikova, M. V. Novikova, V. I. Pakusina, K. G. Pereverzeva, I. S. Pleshakov, Yu. G. Pokramovich, O. V. Ponomareva, E. A. Popova, N. A. Popova, E. S. Potapova, E. D. Resnyanskaya, M. Yu. Rozhkova, A. O. Rubanenko, M. D. Rudoy, A. S. Salasyuk, L. M. Salimova, V. I. Samokhina, N. Sh. Sanginova, F. I. Sattarova, A. Kh. Safina, D. P. Sirotenko, N. S. Skarzhinskaya, A. V. Skibitsky, E. I. Suchkova, L. E. Tepnadze, A. V. Fendrikova, T. E. Filatova, O. V. Filyushin, O. Yu. Chizhova, T. I. Chudinovskikh, S. S. Yakushin, E. M. Yashina
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 7 (2024)
Aim. To present data from the AURA Registry (real-world data registry on AlbUminuRia detection rate among patients with previously undiAgnosed chronic kidney disease). It is important to perform population studies both to study the occurrence of mark
Externí odkaz:
https://doaj.org/article/e6737166623e4811afc3782016a90baa
Publikováno v:
Фармакоэкономика, Vol 16, Iss 4, Pp 527-536 (2024)
Objective: to evaluate the clinical and economic effectiveness of benralizumab in comparison with standard therapy in patients with severe bronchial asthma (SBA) with an eosinophilic phenotype in the Russian Federation.Material and methods. A clinica
Externí odkaz:
https://doaj.org/article/202ddd6e43c44c1fb5bc1fe93988acc6
Autor:
Sergey V. Nedogoda, Minara S. Shamkhalova, Alla S. Salasyuk, Viktoriya O. Lutova, Irina N. Barykina, Ekaterina A. Popova
Publikováno v:
Клинический разбор в общей медицине, Vol 3 , Iss 2, Pp 33-43 (2024)
Background. The economic costs associated with chronic kidney disease (CKD) are a significant burden on the health care system. The use of dapagliflozin is a breakthrough strategy in the management of patients with CKD and type 2 diabetes mellitus (T
Externí odkaz:
https://doaj.org/article/06239df5d0494751b81ecbd87a40385e
Autor:
Sergey V. Nedogoda, Sergey N. Tereshchenko, Igor V. Zhirov, Alla S. Salasyuk, Irina N. Barykina, Viktoria O. Lutova, Ekaterina A. Popova
Publikováno v:
Терапевтический архив, Vol 95, Iss 9, Pp 782-788 (2023)
Aim. To estimate the cost-effectiveness of dapagliflozin across the range of ejection fraction in patients with heart failure (HF) in Russian Federation. Materials and methods. Cost-effectiveness model was developed for estimate the use of dapagli
Externí odkaz:
https://doaj.org/article/5cdd37a6c334452eaa1cd66c41c48798
Publikováno v:
Сахарный диабет, Vol 25, Iss 6, Pp 564-569 (2023)
Initiation of insulin therapy with basal insulin analogues has become the standard of care for type 2 diabetes mellitus (T2DM). Timely administration of insulin allows not only to slow down the progression of type 2 diabetes, but also to reduce the f
Externí odkaz:
https://doaj.org/article/ff68beab08a84ffbaa0e95729ce3d2cc
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 6 (2023)
Aim. To evaluate the cost-effectiveness of empagliflozin therapy in patients with heart failure (HF) across the ejection fraction (EF) range in the Russian Federation.Material and methods. An analysis of the cost of HF management was carried out
Externí odkaz:
https://doaj.org/article/6a42f026c08e4128a5fc2bd5f0fabca8
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 3, Pp 282-288 (2022)
Aim. To study the dynamics of the lipid profile of hypertensive patients with dyslipidemia who underwent COVID-19.Material and methods. Hypertensive patients with dyslipidemia who underwent COVID-19 [n=126; 58 men and 68 women; median age 60 (56.0; 6
Externí odkaz:
https://doaj.org/article/3915ee1f1d1a4af090be55071a839c4f
Autor:
Salasyuk, A. S., Rudkovskaya, A. V., Danilov, A. P., Glavin, B. A., Kukhtaruk, S. M., Wang, M., Rushforth, A. W., Nekludova, P. A., Sokolov, S. V., Elistratov, A. A., Yakovlev, D. R., Bayer, M., Akimov, A. V., Scherbakov, A. V.
Publikováno v:
Phys. Rev. B 97, 060404 (2018)
A high-amplitude microwave magnetic field localized at the nanoscale is a desirable tool for various applications within the rapidly developing field of nanomagnetism. Here, we drive magnetization precession by coherent phonons in a metal ferromagnet
Externí odkaz:
http://arxiv.org/abs/1712.03027
Autor:
Sergey V. Nedogoda, Alla S. Salasyuk, Irina N. Barykina, Viktoria O. Smirnova, Ekaterina A. Popova
Publikováno v:
Consilium Medicum, Vol 23, Iss 12, Pp 932-938 (2021)
Aim. To evaluate the clinical and economic efficiency of the use of dapagliflozin in patients with chronic kidney disease (CKD) stages 24 in Russian Federation. Materials and methods. Cost-effectiveness (utility) analysis has been carried out. Mat
Externí odkaz:
https://doaj.org/article/b9992e3ad34c40bbb6a68a407c78ccd3